Medical News

RSS

Aidspan publishes new issue of 'Global Fund Observer'

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Monday published Issue 198 of its "Global Fund Observer."

15 Oct 2012

Civitas to present CVT-301 Phase 1 study results at Parkinson's Disease Therapeutics Conference

Civitas Therapeutics, Inc., a privately-held pharmaceutical company developing transformative therapeutics using the ARCUS respiratory delivery platform, announced today that the Company will make its first public presentation at the Sixth Annual Parkinson's Disease Therapeutics Conference, sponsored by The Michael J. Fox Foundation for Parkinson's Research, to be held on October 24th in New York City.

15 Oct 2012

Women's decisions about contraception may depend on factors over which they have little control

Young women who start using hormonal contraceptives for birth control often stop using condoms, but a new study in the Journal of Adolescent Health finds that if they later discontinue using hormonal contraceptives, they tend not to resume using condoms. This leaves them open to both unintended pregnancy and sexually transmitted infections (STIs).

15 Oct 2012

Questions abound on compounding pharmacies after meningitis outbreak

Compounding pharmacies continue to face intense scrutiny over their drug preparation and lobbying habits after one in Massachusetts is suspected in distributing a steroid that led to a meningitis outbreak.

15 Oct 2012

Enrollment complete in Idera's IMO-3100 Phase 2 trial for psoriasis

Idera Pharmaceuticals today announced that it had completed patient enrollment in its randomized, double-blind, placebo-controlled Phase 2 trial of IMO-3100 in patients with moderate-to-severe plaque psoriasis. IMO-3100 is an antagonist of specific Toll-like Receptors (TLRs) that the Company is developing for the treatment of psoriasis and other autoimmune diseases.

15 Oct 2012

DNA method leads to more effective treatment of neuroblastoma in children

After leukaemia and brain tumours, neuroblastoma is the most common form of cancer to affect children. A thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden, has studied a DNA method which is now used for all cases of neuroblastoma in Sweden, and which has led to more effective treatment at individual level.

15 Oct 2012

U.S. can draw lessons from PEPFAR success to address epidemic in black America

"Thirty years ago, the CDC reported the first cases of HIV/AIDS in New York and Los Angeles," Foreign Policy In Focus columnist Kwei Quartey writes in the Huffington Post World Blog, noting, "Since the beginning of the epidemic, over 600,000 people have died of AIDS in the United States, and 1.2 million people are currently living with HIV."

15 Oct 2012

New radiation treatment techniques can reduce risk of neurocognitive adverse effects in children

Children who undergo brain radiation therapy run a significant risk of suffering from permanent neurocognitive adverse effects. These adverse effects are due to the fact that the radiation often encounters healthy tissue. This reduces the formation of new cells, particularly in the hippocampus - the part of the brain involved in memory and learning.

15 Oct 2012

Critical Diagnostics signs agreements with four new European distributors

Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases, today announced that it has signed agreements with four new European distributors in Germany, Spain, France and Turkey.

15 Oct 2012

FIGHT HLH Consortium receives EUR 6 million FP7 grant for testing NovImmune's NI-0501

NovImmune SA announced that the European Commission has awarded a 6 million Euros FP7 grant to the "FIGHT HLH" consortium of institutions to support clinical testing of NovImmune's anti-interferon gamma drug candidate, NI-0501.

15 Oct 2012

Health care, Medicare will pose major challenges to the winner

The victor of the presidential contest will face huge policy decisions including how to maintain Medicare's solvency and whether to implement the 2010 health law. News outlets analyze where President Barack Obama and GOP presidential hopeful Mitt Romney stand on these issues.

15 Oct 2012

Bruker launches robust ContourGT-I 3D Optical Microscope

Bruker announced the launch today of the ContourGT-I 3D Optical Microscope to enhance R&D productivity and maximize manufacturing throughput for industrial applications. The ContourGT-I has been optimized to accelerate and simplify measurement setup and feature-tracking and is the world's first bench top profiling system to incorporate Bruker's proprietary tip/tilt head design, along with fully automated functionality, including turret, lenses, and illumination.

From Bruker Nano Surfaces and Metrology 15 Oct 2012

Females having multiple sexual partners may be more fertile

Researchers have discovered that females that have multiple sexual partners can be more fertile than those that are monogamous and, very surprisingly, that this is the result of an "overproduction" of sons. The study - still only published as a provisional article but already one of the most accessed in BCM Evolutionary Biology - helps to explain a puzzle that has been haunting evolutionary biologist for decades: why during a mating season so many females chase multiple sexual partners when one is enough to fertilize all her eggs and to do it is costly and dangerous.

15 Oct 2012

Smoking cessation programs must be made available for current active-duty war fighters

In a new study published in Frontiers, Dr Timothy Durazzo and colleagues from the San Francisco VA Medical Center and University of California, San Francisco, expand upon their decade of research showing that smoking while kicking the alcohol habit impairs memory, learning and other cognitive skills--ultimately making it more difficult to weather the long storm of sobriety.

15 Oct 2012

Regulatory B cells may provide effective treatment for severe autoimmune diseases

Reproducing a rare type of B cell in the laboratory and infusing it back into the body may provide an effective treatment for severe autoimmune diseases such as multiple sclerosis or rheumatoid arthritis, according to researchers at Duke University Medical Center.

15 Oct 2012

First Edition: October 15, 2012

Today's headlines include the latest developments and polling news from the presidential campaign trail as well as details about how Medicare and other health issues are shaping up in House and Senate races.

15 Oct 2012

Merck, AiCuris enter licensing agreement for novel HCMV candidates

Merck, known as MSD outside the United States and Canada, and AiCuris today announced that they have entered into an exclusive worldwide licensing agreement for AiCuris' novel portfolio of investigational medicines targeting Human Cytomegalovirus (HCMV), including letermovir (AIC246), an oral, late-stage antiviral candidate being investigated for the treatment and prevention of HCMV infection in transplant recipients.

15 Oct 2012

Maryland professor receives 2012 Distinguished Service Award from AAPS

Larry Augsburger, PhD, professor emeritus at the University of Maryland School of Pharmacy, has received the 2012 Distinguished Service Award of the American Association of Pharmaceutical Scientists (AAPS), one of the highest honors bestowed by the group of 12,000 members in more than 70 countries.

15 Oct 2012

New research on how the brain develops during transition period from childhood to adulthood

Scientists presented new research today on how the brain develops during the dynamic and vulnerable transition period from childhood to adulthood. The findings underscore the uniqueness of adolescence, revealing factors that may influence depression, decision-making, learning, and social relationships.

15 Oct 2012

White blood cell variation can help predict non-blood cancers

Postdoctoral Research Fellow Devin Koestler is a biostatistician in the Geisel School of Medicine at Dartmouth. He develops and applies statistical methods to large volumes of data, seeking new approaches for understanding disease, cancer in particular. Koestler and his colleagues are investigating the potential use of white blood cell variation as a diagnostic, predictive, and research tool in the study of non-blood cancers.

15 Oct 2012